Raleigh’s BioDelivery Sciences secures rights for opioid-induced constipation drug
The med, Symproic, is used to treat OIC in adults with chronic non-cancer pain, and has the potential to become a leading therapy option for OIC given its proven clinical profile and differentiation.
Read More
